Projected 30- day out-of-pocket costs and total spending on pancreatic enzyme replacement therapy under Medicare Part D

Arjun Gupta, Naveen Premnath, Ramy Sedhom, Muhammad S. Beg, Rohan Khera, Daniel A. Laheru, Stacie B. Dusetzina

Research output: Contribution to journalLetterpeer-review

3 Scopus citations
Original languageEnglish (US)
Pages (from-to)1009-1010
Number of pages2
JournalPancreatology
Volume21
Issue number5
DOIs
StatePublished - Aug 2021

Keywords

  • Cost
  • Exocrine pancreatic insufficiency
  • Medicare
  • Pancreatic ductal adenocarcinoma (PDAC)
  • Pancreatic enzymes

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Hepatology
  • Gastroenterology

Cite this